Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluation of Microrna-125B-5P and Transcription Factors Blimp1 and Irf4 Expression in Unsolved Common Variable Immunodeficiency Patients Publisher Pubmed



Esfahani ZH1, 2 ; Yazdani R2 ; Shahkarami S2, 3, 4 ; Babaha F1, 2 ; Abolhassani H2, 5, 6 ; Sadr M7 ; Pourfathollah AA1 ; Aghamohammadi A2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
  2. 2. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Pediatrics, University Hospital, Ludwig-Maximilians-Universitat Munchen (LMU), Munich, Germany
  4. 4. Medical Genetics Network (Megene), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  5. 5. Department of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden
  6. 6. Department of Biosciences and Nutrition, Division of Clinical Immunology, Karolinska Institute, Huddinge, Sweden
  7. 7. Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Allergy# Asthma and Immunology Published:2021


Abstract

Common variable immunodeficiency (CVID) is the most prevalent form of symptomatic primary humoral immunodeficiencies characterized by failure in the final differentiation of B lymphocytes. The majority of CVID cases have no identified genetic defect, and epigenetic alteration could be involved in the pathogenesis of CVID. Hence, we aimed to evaluate the expression of hsa-miR-125b-5p -and, B lymphocyte-induced maturation protein-1(BLIMP-1) and interferon regulatory protein-4 (IRF-4) in a group of CVID patients with no definitive genetic diagnosis in comparison with healthy individuals. Ten CVID patients (all known genes excluded) and 10 age and sex-matched healthy controls participated in the study. B lymphocytes were isolated and expression of miR-125b-5p, IRF4, and BLIMP1 were evaluated by real-time polymerase chain reaction (RT-PCR). Moreover, B cell subsets were analyzed by flow cytometry. The results showed that the relative expression of miR-125b-5p in CVID patients was increased while it was decreased for the BLIMP1 and IRF4 transcription factors compared with the healthy controls. Although a reduction was observed in switched and non-switched memory B cells among all high-miR patients, these subsets were decreased in patients with normal miR expression (71.0% and 85.0%, respectively). Our results suggest that overexpression of miR-125b-5p affects the terminal differentiation of B cells in a selected group of CVID patients by downregulating the BLIMP-1 gene and more intensively for the IRF-4 gene expressions. Copyright © 2021 Hamidi Esfahani et al.
Other Related Docs
17. The Clinical and Immunological Features of Patients With Primary Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2018)
20. Global Systematic Review of Primary Immunodeficiency Registries, Expert Review of Clinical Immunology (2020)
23. A Review on Defects of Dendritic Cells in Common Variable Immunodeficiency, Endocrine# Metabolic and Immune Disorders - Drug Targets (2017)
25. Application of Flow Cytometry in Predominantly Antibody Deficiencies, Endocrine# Metabolic and Immune Disorders - Drug Targets (2021)
29. Role of Apoptosis in the Pathogenesis of Common Variable Immunodeficiency (Cvid), Endocrine# Metabolic and Immune Disorders - Drug Targets (2017)
32. B Cells and T Cells Abnormalities in Patients With Selective Iga Deficiency, Allergy# Asthma and Clinical Immunology (2023)
33. New Presentation of Cd27 Deficiency; Coronary Ectasia and Covid-19, Iranian Journal of Allergy# Asthma and Immunology (2023)
39. Respiratory Complications in Patients With Hyper Igm Syndrome, Journal of Clinical Immunology (2019)
41. Pharmacoepigenetics of Immunological Disorders, Pharmacoepigenetics (2019)
45. Approach to the Management of Autoimmunity in Primary Immunodeficiency, Scandinavian Journal of Immunology (2017)